Abiopharma

🔍 Smith Richard W (Director)

Company: FEDEX CORP (FDX)

Report Date: 2025-06-23

Detailed Transactions and Holdings:

• Acquired 253,927 shares of Common Stock (Direct)
  Date: 2025-06-23 | Code: W | equity_swap_involved: 0 | shares_owned_after: 253,927.00 | transaction_form_type: 5 | Footnotes: F1
• Acquired 2,262 shares of Common Stock (Direct)
  Date: 2026-01-07 | Code: G | equity_swap_involved: 0 | shares_owned_after: 106,694.00 | transaction_form_type: 5
• Sold 600 shares of Common Stock (Direct)
  Date: 2026-04-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 79,600.00 | transaction_form_type: 4
• Acquired 600 shares of Common Stock (Direct)
  Date: 2026-04-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 107,294.00 | transaction_form_type: 4
• Acquired 3,805 shares of Common Stock at $162.82 per share (Direct)
  Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 111,099.00 | transaction_form_type: 4
• Sold 2,204 shares of Common Stock at $366.905 per share (Direct)
  Date: 2026-04-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,895.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 3,805 shares of Non-qualified Stock Option (Right to Buy) at $162.82 per share (Derivative)
  Date: 2026-04-14 | Code: M | Expires: 2026-06-06 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: These shares of FedEx common stock were transferred to the Reporting Person upon termination of a family trust and are held by a family holding company in which Mr. Smith has shared voting and investment power.
• F2: Represents the number of shares withheld by the Issuer as a result of the net exercise of stock options and used to pay the exercise price and required tax withholdings in accordance with the FedEx's 2010 Omnibus Stock Incentive Plan.
• F3: These options vest ratably over four years from the date of grant and are first exercisable one year from date of grant.